The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers

Nav

General Info

Geography

Austria (AUT)

Norway (NOR)

Sweden (SWE)

Coverage type

Country

Time period covered

01/1972 - 12/2014

Data type

Scientific literature

Keywords

Body mass index, Breast cancer, Colon and rectum cancers, Corpus uteri cancer, Gallbladder and biliary tract cancers, Kidney and other urinary organ cancers, Liver cancer, Oesophagus cancer, Ovary cancer, Pancreas cancer

Citation

Authors

Fritz J, Bjørge T, Nagel G, Manjer J, Engeland A, Häggström C, Concin H, Teleka S, Tretli S, Gylling B, Lang A, Stattin P, Stocks T, Ulmer H

Journal

Int J Epidemiol

Volume

Issue

Pages

193-204

Publication year

2020

Suggested citation

Fritz J, Bjørge T, Nagel G, Manjer J, Engeland A, Häggström C, Concin H, Teleka S, Tretli S, Gylling B, Lang A, Stattin P, Stocks T, Ulmer H. The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers. Int J Epidemiol. 2020; 49(1): 193-204.

DOI

10.1093/ije/dyz053

PMID

30945727

GHDx Entry last modified on: Dec 12, 2023

Main menu

The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers

Nav